Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |